Abstract Search

ea0063p946 | Diabetes, Obesity and Metabolism 3 | ECE2019

Screening of abnormal glucose metabolism in cystic fibrosis could there be a place for DPP-4 inhibitors in early stages?

Peris Begona Pla , Sanchez Clara Marijuan , Moreno Nerea Aguirre , Alday Inigo Hernando , Blanco Sara Jimenez , Nunez Miguel Sampedro , Moreno Rosa Giron , Azpiroz Monica Marazuela , Martin Alfonso Arranz

Introduction: Abnormal glucose metabolism (AGM) is the most common extra-pulmonary comorbidity in people with cystic fibrosis (CF) and has a high negative impact on the underlying disease. Elevated postprandial glucose level is usually the first manifestation, which is traditionally detected by 75-gram oral glucose tolerance test (OGTT). The aim of this study was to evaluate glycemic pattern during continuous glucose monitoring (CGM) in patients with impaired glucose metabolis...

1 shares

ea0049ep574 | Diabetes complications | ECE2017

Characteristics of patients with cystic fibrosis and hydrocarbon alteration in an adult unit

Gonzalez Elena Fernandez , Moreno Nerea Aguirre , Caceres Layla Diab , Gutierrez Carmen Acosta , Ramos-Levi Ana , Nunez Miguel Sampedro , Moreno Isabel Huguet , Azpiroz Monica Marazuela , Moreno Rosa Maria Giron , Martin Alfonso Arranz

Introduction: Hydrocarbon Alteration (HA) is considered as the most common complication in Cystic Fibrosis (CF) and is related to a further deterioration of the lung function and the nutritional status.Objective: Analyze the prevalence of HA in patients with CF in an adult unit and its relationship with pulmonary complications.Material and methods: We conducted a retrospective study with 71 patients of our CF unit (age 30+/−9...

1 shares

Endocrine Abstracts

Screening of abnormal glucose metabolism in cystic fibrosis could there be a place for DPP-4 inhibitors in early stages?

Characteristics of patients with cystic fibrosis and hydrocarbon alteration in an adult unit

BiosciAbstracts